Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
285
datasets available to search
ShareScore release 0.9.0
Dataset results
285 results for “regorafenib”
Regorafenib Monotherapy as Second-line Treatment of Patients With RAS-mutant Advanced Colorectal Cancer
ClinicalTrials.gov study NCT02619435. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Metastatic Colorectal Cancer Treated With Regorafenib and FOLFIRI
ClinicalTrials.gov study NCT03698253. IPD Sharing: NO. Countries: 1. Publications: 0.
Assessment of Physical Activity During Therapy With Regorafenib for Metastatic Colorectal Cancer
ClinicalTrials.gov study NCT02347852. IPD Sharing: Not stated. Countries: 1. Publications: 0.
The Effect of Food (High Fat and Low Fat Breakfast) on the Pharmacokinetics of Regorafenib
ClinicalTrials.gov study NCT01002378. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Regorafenib in Good Performance Status Patients With Newly Diagnosed Metastatic Colorectal Adenocarcinoma
ClinicalTrials.gov study NCT02023333. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Tauroursodeoxycholic Acid (TUDCA) Plus Camrelizumab and Regorafenib in Hepatocellular Carcinoma Previously Treated With Anti-PD1/PD-L1 and Bevacizumab
ClinicalTrials.gov study NCT07100392. IPD Sharing: NO. Countries: 1. Publications: 0.
Hepatic Arterial Infusion Chemotherapy Combined With Sintilimab and Regorafenib as Adjuvant Therapy for Colorectal Liver Metastasis Patients With a High Risk of Recurrent: a Single-arm, Phase II Study
ClinicalTrials.gov study NCT05753163. IPD Sharing: NO. Countries: 1. Publications: 0.
Phase Ib / Regorafenib With Conventional Chemotherapy/Newly Diagnosed Patients/ Multimetastatic Ewing Sarcoma
ClinicalTrials.gov study NCT05830084. IPD Sharing: NO. Countries: 6. Publications: 0.
Regorafenib, C-kit Mutated Malignant Melanoma, 2nd Line Therapy
ClinicalTrials.gov study NCT02501551. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Phase 2 Study to Evaluate the Efficacy of Regorafenib in Specific GIST Mutation Subsets (KIT Exon 17, 18, or 14 Mutation and SDHB Deficient GIST) in the Post-imatinib Second-line Setting.
ClinicalTrials.gov study NCT06087263. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Efficacy and Safety Study of DC-CIK Cell Therapy Combined With Epaloliposide, Vortexil, and Regorafenib as Third-line Treatment for Advanced Colorectal Cancer.
ClinicalTrials.gov study NCT07343791. IPD Sharing: NO. Countries: 1. Publications: 0.
An Observational Study Called STAR-T to Learn More About the Sequential Treatment With Regorafenib and TAS-102 in Adults With Metastatic Colorectal Cancer Under Real World Conditions
ClinicalTrials.gov study NCT05839951. IPD Sharing: NO. Countries: 1. Publications: 0.
Efficacy and Safety of Pracytarabine Versus Regorafenib in the Treatment of Patients With Hepatocellular Carcinoma
ClinicalTrials.gov study NCT07300488. IPD Sharing: NO. Countries: 1. Publications: 0.
ctDNA-Guided Sunitinib And Regorafenib Therapy for GIST
ClinicalTrials.gov study NCT05366816. IPD Sharing: NO. Countries: 1. Publications: 0.
Real World Study of Regorafenib Versus Fruquintinib in Colorectal Cancer
ClinicalTrials.gov study NCT04431791. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Efficacy and Safety of Sintilimab Combined With Regorafenib and Cetuximab / Sintilimab Combined With Regorafenib in Posterior Line Therapy of Advanced Colorectal Cancer (Regosinti)
ClinicalTrials.gov study NCT04745130. IPD Sharing: YES. Countries: 1. Publications: 0.
The Safety and Efficacy of HAIC+Tislelizumab+Regorafenib in Patients With Colorectal Liver Metastases
ClinicalTrials.gov study NCT05877001. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Use of Regorafenib in Recurrent Epithelial Ovarian Cancer
ClinicalTrials.gov study NCT02736305. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
A Study Evaluating Cadonilimab Injection in Combination With Regorafenib for the Advanced Hepatocellular Carcinoma
ClinicalTrials.gov study NCT05644379. IPD Sharing: NO. Countries: 1. Publications: 0.
Dose-escalation of Regorafenib in Advanced Hepatocellular Carcinoma
ClinicalTrials.gov study NCT05622136. IPD Sharing: NO. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.